PROPANC BIOPHARMA, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PROPANC BIOPHARMA, INC. (PPCB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $0 for the 6-month period ending 2016-12-31, per its 10-Q filed 2017-02-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-09-28
- PROPANC BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$9.20K.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $0.00.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$9.88K.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$5.58K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | $0.00 10-Q · filed 2017-02-14 | -$9.20K derived: sum of 3 quarters · filed 2017-09-28 | -$9.20K derived: sum of 4 quarters · filed 2017-09-28 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | -$9.20K derived: sum of 2 quarters · filed 2017-09-28 | -$9.20K derived: sum of 3 quarters · filed 2017-09-28 | -$9.20K derived: sum of 4 quarters · filed 2017-09-28 | |
| 2016-06-30 | -$9.20K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$9.20K derived: sum of 2 quarters · filed 2017-09-28 | -$9.20K derived: sum of 3 quarters · filed 2017-09-28 | -$9.88K 10-K · filed 2017-09-28 | -$12.06K 10-K · filed 2016-09-28 |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $3.00 derived: sum of 2 quarters · filed 2017-05-08 | -$676.00 10-Q · filed 2017-05-08 | ||
| 2015-12-31 | $3.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | -$676.00 10-Q · filed 2017-02-14 | |||
| 2015-09-30 | -$679.00 10-Q · filed 2016-11-10 | ||||
| 2015-06-30 | -$5.58K 10-K · filed 2016-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |